Ex vivo biodistribution data also indicated thatthe tumor/blood ratio for PSMA-positive tumors (11.1 ± 1.4) wassignificantly higher than that for PSMA-negative tumors (3.9 ±3.0) at 2 h p.i. (p = 0.0385). The gene discussed is FOLH1; the disease is neoplasm.